Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Factor

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|October 30, 1998
Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cellsV N Gladyshev, V M Factor, F Housseau, et al.
Cancer Research|March 31, 2001
Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor gradeD F Calvisi, V M Factor, R Loi, et al.
The American Journal of Pathology|June 11, 1999
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruptionE Santoni-Rugiu, M R Jensen, V M Factor, et al.
The American Journal of Pathology|August 1, 1996
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alphaE Santoni-Rugiu, P Nagy, M R Jensen, et al.
The Journal of Biological Chemistry|June 23, 1998
Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesisV M Factor, A Kiss, J T Woitach, et al.
Oncogene|July 21, 2009
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic propertiesC Coulouarn, V M Factor, J B Andersen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 1999
Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver diseaseK H Preisegger, V M Factor, A Fuchsbichler, et al.
Cancer Research|September 2, 2000
Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivoB Bouzahzah, M Fu, A Iavarone, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Reconstitution of liver mass via cellular hypertrophy in the ratP Nagy, T Teramoto, V M Factor, et al.
Oncogene|October 24, 2000
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesisE A Conner, E R Lemmer, M Omori, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|October 30, 1998
Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cellsV N Gladyshev, V M Factor, F Housseau, et al.
Cancer Research|March 31, 2001
Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor gradeD F Calvisi, V M Factor, R Loi, et al.
The American Journal of Pathology|June 11, 1999
Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruptionE Santoni-Rugiu, M R Jensen, V M Factor, et al.
The American Journal of Pathology|August 1, 1996
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alphaE Santoni-Rugiu, P Nagy, M R Jensen, et al.
The Journal of Biological Chemistry|June 23, 1998
Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesisV M Factor, A Kiss, J T Woitach, et al.
Oncogene|July 21, 2009
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic propertiesC Coulouarn, V M Factor, J B Andersen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 1999
Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver diseaseK H Preisegger, V M Factor, A Fuchsbichler, et al.
Cancer Research|September 2, 2000
Transforming growth factor-beta1 recruits histone deacetylase 1 to a p130 repressor complex in transgenic mice in vivoB Bouzahzah, M Fu, A Iavarone, et al.
Hepatology (Baltimore, Md.)|February 15, 2001
Reconstitution of liver mass via cellular hypertrophy in the ratP Nagy, T Teramoto, V M Factor, et al.
Oncogene|October 24, 2000
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesisE A Conner, E R Lemmer, M Omori, et al.
Pageof 4